{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "20455016", "DateCompleted": {"Year": "2011", "Month": "01", "Day": "13"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "20"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1007/s11011-010-9189-7"], "ArticleDate": [{"Year": "2010", "Month": "05", "Day": "09"}], "Journal": {"ISSN": "1573-7365", "JournalIssue": {"Volume": "25", "Issue": "2", "PubDate": {"Year": "2010", "Month": "Jun"}}, "Title": "Metabolic brain disease", "ISOAbbreviation": "Metab Brain Dis"}, "ArticleTitle": "Ozone modulates the effects of imipramine on immobility in the forced swim test, and nonspecific parameters of hippocampal oxidative stress in the rat.", "Pagination": {"StartPage": "125", "EndPage": "133", "MedlinePgn": "125-33"}, "Abstract": {"AbstractText": ["Depression has been associated with oxidative stress. There is increased awareness of the role of environmental toxins in the development of mood disorders. Ozone, a pro-oxidant and environmental pollutant, has been noted to have central nervous system effects. We investigated the effects of acute and chronic ozone inhalation on the response of imipramine in the forced-swim test (FST) and on biomarkers of oxidative stress in rat hippocampus. Sprague Dawley rats were exposed to 0, 0.25 or 0.7 ppm ozone per inhalation 4 h daily for either 30 days (chronic) or once (acute). Animals were then injected intraperitoneally with imipramine (10 mg/kg) or saline 24, 5 and 1 h before the forced-swim test. Hippocampal superoxide accumulation and lipid peroxidation were measured. Imipramine evoked an antidepressant-like effect independent of acute or chronic ozone exposure. However, 0.7 ppm acute ozone and 0.25 ppm chronic ozone attenuated the antidepressant-like effects of imipramine. The ozone exposures also elevated hippocampal superoxide accumulation and lipid peroxidation. Importantly, imipramine reversed the lipid peroxidation induced by chronic ozone, thereby preventing cellular damage induced by oxidative stress. Ozone exposure presents a feasible model with etiological validity to investigate oxidative stress in depression and antidepressant action."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "North-West University, Potchefstroom, 2520, South Africa."}], "Identifier": [], "LastName": "Mokoena", "ForeName": "Mmalebuso L", "Initials": "ML"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Harvey", "ForeName": "Brian H", "Initials": "BH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Oliver", "ForeName": "Douglas W", "Initials": "DW"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Brink", "ForeName": "Christiaan B", "Initials": "CB"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Metab Brain Dis", "NlmUniqueID": "8610370", "ISSNLinking": "0885-7490"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antidepressive Agents, Tricyclic"}, {"RegistryNumber": "0", "NameOfSubstance": "Hazardous Substances"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "OGG85SX4E4", "NameOfSubstance": "Imipramine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antidepressive Agents, Tricyclic"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Depressive Disorder"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["antagonists & inhibitors", "toxicity"], "DescriptorName": "Hazardous Substances"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Hippocampus"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Imipramine"}, {"QualifierName": [], "DescriptorName": "Immobilization"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["antagonists & inhibitors", "toxicity"], "DescriptorName": "Ozone"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Physical Exertion"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["physiology"], "DescriptorName": "Swimming"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Neurosci Lett. 1996 Feb 2;204(1-2):49-52", "ArticleIdList": ["8929975"]}, {"Citation": "Neurosci Lett. 1999 Jul 30;270(2):107-9", "ArticleIdList": ["10462109"]}, {"Citation": "Metab Brain Dis. 2006 Sep;21(2-3):211-20", "ArticleIdList": ["16865538"]}, {"Citation": "J Psychiatry Neurosci. 2000 Jan;25(1):43-7", "ArticleIdList": ["10721683"]}, {"Citation": "Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1387-92", "ArticleIdList": ["12552118"]}, {"Citation": "Eur Neuropsychopharmacol. 2008 Feb;18(2):128-40", "ArticleIdList": ["17566715"]}, {"Citation": "Eur J Neurosci. 2001 Jul;14(1):161-6", "ArticleIdList": ["11488960"]}, {"Citation": "Physiol Rev. 1998 Apr;78(2):547-81", "ArticleIdList": ["9562038"]}, {"Citation": "Int J Neurosci. 2001;108(3-4):149-61", "ArticleIdList": ["11699188"]}, {"Citation": "Eur J Biochem. 1993 Jul 15;215(2):213-9", "ArticleIdList": ["7688300"]}, {"Citation": "Toxicol Pathol. 2002 Nov-Dec;30(6):620-50", "ArticleIdList": ["12512863"]}, {"Citation": "Neurochem Res. 2008 Mar;33(3):508-17", "ArticleIdList": ["17763945"]}, {"Citation": "J Affect Disord. 2001 Apr;64(1):43-51", "ArticleIdList": ["11292519"]}, {"Citation": "Eur J Pharmacol. 1978 Feb 15;47(4):379-91", "ArticleIdList": ["204499"]}, {"Citation": "Brain Res Dev Brain Res. 2001 Nov 26;131(1-2):149-52", "ArticleIdList": ["11718845"]}, {"Citation": "Prog Neurobiol. 2005 Feb;75(3):207-46", "ArticleIdList": ["15882775"]}, {"Citation": "Hippocampus. 2008;18(7):631-9", "ArticleIdList": ["18306301"]}, {"Citation": "Physiol Behav. 2002 Dec;77(4-5):601-5", "ArticleIdList": ["12527006"]}, {"Citation": "Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):220-8", "ArticleIdList": ["19059298"]}, {"Citation": "Neurochem Int. 2004 Dec;45(7):979-86", "ArticleIdList": ["15337296"]}, {"Citation": "Curr Opin Pharmacol. 2007 Feb;7(1):18-21", "ArticleIdList": ["17049922"]}, {"Citation": "Eur J Pharmacol. 2004 Aug 16;497(1):49-53", "ArticleIdList": ["15321734"]}, {"Citation": "J Vis Exp. 2007;(7):269", "ArticleIdList": ["18989440"]}, {"Citation": "J Neurochem. 1992 Nov;59(5):1609-23", "ArticleIdList": ["1402908"]}, {"Citation": "Am J Psychiatry. 2003 Aug;160(8):1516-8", "ArticleIdList": ["12900317"]}, {"Citation": "Redox Rep. 2008;13(2):87-100", "ArticleIdList": ["18339251"]}, {"Citation": "Brain Res. 2003 Jan 3;959(1):128-34", "ArticleIdList": ["12480166"]}, {"Citation": "Exp Physiol. 1997 Mar;82(2):291-5", "ArticleIdList": ["9129943"]}, {"Citation": "Mutat Res. 2009 Mar 31;674(1-2):62-72", "ArticleIdList": ["18977456"]}, {"Citation": "Anal Biochem. 1976 May 7;72:248-54", "ArticleIdList": ["942051"]}, {"Citation": "Hum Psychopharmacol. 2008 Jul;23(5):371-84", "ArticleIdList": ["18435513"]}, {"Citation": "Pflugers Arch. 1997 Apr;433(6):744-9", "ArticleIdList": ["9049165"]}, {"Citation": "Int J Neuropsychopharmacol. 2009 May;12(4):553-9", "ArticleIdList": ["18976544"]}, {"Citation": "Nat Rev Neurosci. 2009 Jun;10(6):434-45", "ArticleIdList": ["19401723"]}, {"Citation": "Free Radic Biol Med. 2005 Feb 15;38(4):515-26", "ArticleIdList": ["15649654"]}, {"Citation": "Int J Neuropsychopharmacol. 2010 May;13(4):461-73", "ArticleIdList": ["19627650"]}, {"Citation": "Neurosci Lett. 1999 Oct 15;274(1):1-4", "ArticleIdList": ["10530505"]}, {"Citation": "Eur J Pharmacol. 2007 Oct 15;572(1):23-31", "ArticleIdList": ["17610875"]}, {"Citation": "Neuropsychopharmacology. 2008 Jan;33(1):88-109", "ArticleIdList": ["17851537"]}, {"Citation": "Environ Res. 1998 Jan;76(1):33-9", "ArticleIdList": ["9466895"]}, {"Citation": "Am J Psychiatry. 2004 Nov;161(11):1957-66", "ArticleIdList": ["15514393"]}, {"Citation": "Am J Clin Nutr. 1991 Jan;53(1 Suppl):194S-200S", "ArticleIdList": ["1985387"]}, {"Citation": "Biol Psychiatry. 2004 Aug 1;56(3):140-5", "ArticleIdList": ["15271581"]}, {"Citation": "Arch Environ Health. 1975 Aug;30(8):373-8", "ArticleIdList": ["1164043"]}, {"Citation": "Med Hypotheses. 2009 Mar;72(3):338-41", "ArticleIdList": ["19027246"]}, {"Citation": "Environ Res. 2000 Jan;82(1):7-17", "ArticleIdList": ["10677142"]}, {"Citation": "Neuropsychopharmacology. 2006 Jun;31(6):1165-76", "ArticleIdList": ["16205774"]}, {"Citation": "Int J Neuropsychopharmacol. 2008 Sep;11(6):851-76", "ArticleIdList": ["18205981"]}, {"Citation": "Free Radic Biol Med. 1991;11(1):41-6", "ArticleIdList": ["1937128"]}]}], "History": [{"Year": "2010", "Month": "1", "Day": "20"}, {"Year": "2010", "Month": "2", "Day": "25"}, {"Year": "2010", "Month": "5", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "5", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "1", "Day": "14", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["20455016", "10.1007/s11011-010-9189-7"]}}], "PubmedBookArticle": []}